๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease

โœ Scribed by Roger W. Rodgers; Jess F. Gamble; K. K. Loh; C. C. Shullenberger


Book ID
102666931
Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
594 KB
Volume
46
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Combination chemotherapy of advanced pre
โœ Levi, John A. ;Wiernik, Peter H. ;Diggs, Charles H. ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 567 KB

## Abstract Seventeen patients with advanced, previously treated Hodgkin's disease received therapy with a combination of streptozotocin 500 mg/m^2^ /day i.v. days 1โ€“5, CCNU 100 mg/m^2^ orally day 1, adriamycin 45 mg/m^2^ i.v. day 1, and bleomycin 15 mg/m^2^ i.m. days 1 and 8 at 28โ€day intervals (S

Treatment of Hodgkin's disease in childr
โœ van den Berg, Henk; Stuve, Wouter; Behrendt, Henk ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 2 views

Since the introduction of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy, children with Hodgkin's disease (HD) have been treated with chemotherapy alone. The occurrence of side effects related to irradiation (especially secondary solid tumors) is less likely to occur.